in

A ‘science first’ approach to making COVID-19 vaccines, says Singapore pharmaceutical industry body

SINGAPORE: Pharmaceutical firms are committed to a “science first” approach in the development of COVID-19 vaccines even as the pressure piles on amid a global race to end the pandemic, said a representative from an industry body in Singapore.

Vaccine development is traditionally a complex task …

Reference